Literature DB >> 1635586

A muscarinic receptor different from the M1, M2, M3 and M4 subtypes mediates the contraction of the rabbit iris sphincter.

I T Bognar1, U Altes, C Beinhauer, I Kessler, H Fuder.   

Abstract

In order to analyse the subtype of muscarinic receptors involved in the methacholine-induced contraction of the rabbit iris sphincter we have determined equilibrium dissociation constants (KB) of various antagonists in the sphincter muscle. The values were compared with those observed at M1 (rabbit vas deferens), M2 (heteroreceptors in rat iris) and M3 receptors (guinea-pig ileum), or at the muscarinic receptors in the guinea-pig uterus. The methacholine-induced contraction of the uterus from immature guinea-pigs was competitively antagonized by pirenzepine (6.64, -log KB), 4-DAMP (8.39), hexahydrodifenidol (HHD; 7.00 for the (R)- and 5.40 for the (S)-enantiomer), p-fluoro-hexahydrosiladifenidol (p-F-HHSiD; 6.25) and valethamate bromide (8.04). The affinity of the antagonists is consistent with the presence of an M2 receptor. The -log KB values of the antagonists in the rabbit iris sphincter (6.43, p-F-HHSiD; 6.22, AQ-RA 741; 7.23 and 5.34, (R)- and (S)-trihexyphenidyl) were lower than, or within the lowest range of, estimates in the other experimental models, irrespective of the subtype selectivity of the antagonist. This excludes the presence of an M1, M2, M3 or M4 receptor in this smooth muscle. The affinity of UH-AH 37 in the iris was intermediate between that for M1 or M3, and M2 receptors. The low affinity of AQ-RA 741 and the low enantiomeric ratio of trihexyphenidyl (THP) in the iris (77.6) would be compatible with a presumed M5 receptor.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1635586     DOI: 10.1007/bf00164573

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  27 in total

1.  Characterization of the muscarinic receptor subtype mediating contractions of the guinea-pig uterus.

Authors:  R M Eglen; A D Michel; R L Whiting
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

Review 2.  The molecular basis of muscarinic receptor diversity.

Authors:  T I Bonner
Journal:  Trends Neurosci       Date:  1989-04       Impact factor: 13.837

3.  Identification of a family of muscarinic acetylcholine receptor genes.

Authors:  T I Bonner; N J Buckley; A C Young; M R Brann
Journal:  Science       Date:  1987-07-31       Impact factor: 47.728

4.  Different muscarine receptors mediate the prejunctional inhibition of [3H]-noradrenaline release in rat or guinea-pig iris and the contraction of the rabbit iris sphincter muscle.

Authors:  H Fuder; J Schöpf; J Unckell; M T Wesner; C Melchiorre; R Tacke; E Mutschler; G Lambrecht
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

5.  Stereoselectivity of the enantiomers of trihexyphenidyl and its methiodide at muscarinic receptor subtypes.

Authors:  G Lambrecht; R Feifel; U Moser; A J Aasen; M Waelbroeck; J Christophe; E Mutschler
Journal:  Eur J Pharmacol       Date:  1988-10-11       Impact factor: 4.432

6.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

7.  The interaction of parafluorohexahydrosiladiphenidol at muscarinic receptors in vitro.

Authors:  R M Eglen; A D Michel; W W Montgomery; E A Kunysz; C A Machado; R L Whiting
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

8.  Stereoselective inhibition of muscarinic receptor subtypes by the enantiomers of hexahydro-difenidol and acetylenic analogues.

Authors:  R Feifel; M Wagner-Röder; C Strohmann; R Tacke; M Waelbroeck; J Christophe; E Mutschler; G Lambrecht
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

9.  M2 muscarinic receptors on the iris sphincter muscle differ from those on iris noradrenergic nerves.

Authors:  I T Bognar; B Baumann; F Dammann; B Knöll; M Meincke; S Pallas; H Fuder
Journal:  Eur J Pharmacol       Date:  1989-04-25       Impact factor: 4.432

10.  Antagonist binding profiles of five cloned human muscarinic receptor subtypes.

Authors:  F Dörje; J Wess; G Lambrecht; R Tacke; E Mutschler; M R Brann
Journal:  J Pharmacol Exp Ther       Date:  1991-02       Impact factor: 4.030

View more
  13 in total

1.  Comparative pharmacology of recombinant human M3 and M5 muscarinic receptors expressed in CHO-K1 cells.

Authors:  N Watson; D V Daniels; A P Ford; R M Eglen; S S Hegde
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

Review 2.  The muscarinic M(5) receptor: a silent or emerging subtype?

Authors:  R M Eglen; S R Nahorski
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

Review 3.  Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder.

Authors:  Paul Abrams; Karl-Erik Andersson; Jerry J Buccafusco; Christopher Chapple; William Chet de Groat; Alison D Fryer; Gary Kay; Alan Laties; Neil M Nathanson; Pankaj Jay Pasricha; Alan J Wein
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

Review 4.  Muscarinic receptors and ligands in cancer.

Authors:  Nirish Shah; Sandeep Khurana; Kunrong Cheng; Jean-Pierre Raufman
Journal:  Am J Physiol Cell Physiol       Date:  2008-11-26       Impact factor: 4.249

5.  Pharmacological characterization of muscarinic receptors in dog isolated ciliary and urinary bladder smooth muscle.

Authors:  A Choppin; R M Eglen
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

6.  Interaction of selective compounds with muscarinic receptors at dispersed intestinal smooth muscle cells.

Authors:  E Barocelli; M Chiavarini; V Ballabeni; F Bordi; M Impicciatore
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

7.  3H-Noradrenaline release from mouse iris-ciliary body: role of presynaptic muscarinic heteroreceptors.

Authors:  Michel Bernhard; Kenneth Takeda; Caroline Keller; Mirko Haslebacher; George N Lambrou; Anne-Ulrike Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-09-16       Impact factor: 3.000

8.  Reactivity of human iris-sphincter to muscarinic drugs in vitro.

Authors:  P N Patil
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-12       Impact factor: 3.000

9.  Cholinergic sensitivity of irides from donors with various pathological conditions and lens implants.

Authors:  P N Patil; T F Mauger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-12       Impact factor: 3.000

10.  In vitro characterization of tripitramine, a polymethylene tetraamine displaying high selectivity and affinity for muscarinic M2 receptors.

Authors:  A Chiarini; R Budriesi; M L Bolognesi; A Minarini; C Melchiorre
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.